AU5154098A - Soluble tie2 receptor - Google Patents

Soluble tie2 receptor

Info

Publication number
AU5154098A
AU5154098A AU51540/98A AU5154098A AU5154098A AU 5154098 A AU5154098 A AU 5154098A AU 51540/98 A AU51540/98 A AU 51540/98A AU 5154098 A AU5154098 A AU 5154098A AU 5154098 A AU5154098 A AU 5154098A
Authority
AU
Australia
Prior art keywords
tie2 receptor
soluble tie2
soluble
receptor
tie2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51540/98A
Inventor
Mark W. Dewhirst
Charles Lin
Kevin G. Peters
Prema S. Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of AU5154098A publication Critical patent/AU5154098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU51540/98A 1996-10-31 1997-10-31 Soluble tie2 receptor Abandoned AU5154098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2940796P 1996-10-31 1996-10-31
US60029407 1996-10-31
PCT/US1997/019597 WO1998018914A1 (en) 1996-10-31 1997-10-31 Soluble tie2 receptor

Publications (1)

Publication Number Publication Date
AU5154098A true AU5154098A (en) 1998-05-22

Family

ID=21848847

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51540/98A Abandoned AU5154098A (en) 1996-10-31 1997-10-31 Soluble tie2 receptor

Country Status (2)

Country Link
AU (1) AU5154098A (en)
WO (1) WO1998018914A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521424B2 (en) 1999-06-07 2003-02-18 Immunex Corporation Recombinant expression of Tek antagonists
AU783960B2 (en) 1999-06-07 2006-01-05 Immunex Corporation Tek antagonists
WO2002016318A1 (en) 2000-08-21 2002-02-28 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
US7658924B2 (en) 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
EP1778264A2 (en) * 2004-06-25 2007-05-02 Licentia, Ltd. Tie receptor and tie ligand materials and methods for modulating female fertility
RU2494108C2 (en) 2006-04-07 2013-09-27 Аерпио Терапетикс, Инк. Human protein tyrosine phosphatase beta binding antibodies (hptpbeta), and use thereof
US7622593B2 (en) 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
EP2671891A3 (en) 2008-06-27 2014-03-05 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
MX2011007420A (en) 2009-07-06 2011-12-14 Akebia Therapeutics Inc Compounds, compositions, and methods for preventing metastasis of cancer cells.
WO2012162561A2 (en) 2011-05-24 2012-11-29 Zyngenia, Inc. Multivalent and monovalent multispecific complexes and their uses
CN104039351A (en) 2011-10-13 2014-09-10 阿尔皮奥治疗学股份有限公司 Methods for treating vascular leak syndrome and cancer
US20150050277A1 (en) 2013-03-15 2015-02-19 Aerpio Therapeutics Inc. Compositions and methods for treating ocular diseases
WO2014144600A2 (en) 2013-03-15 2014-09-18 Viktor Roschke Multivalent and monovalent multispecific complexes and their uses
JP6483148B2 (en) 2014-03-14 2019-03-13 エアーピオ セラピューティクス インコーポレイテッド HPTP-β inhibitor
EP3352856B1 (en) 2015-09-23 2021-08-18 Aerpio Pharmaceuticals, Inc. Activators of tie-2 for use in treating intraocular pressure
AU2020264969A1 (en) 2019-04-29 2021-12-09 EyePoint Pharmaceuticals, Inc. Tie-2 activators targeting the schlemm's canal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US5196320A (en) * 1989-09-20 1993-03-23 Abbott Biotech, Inc. Method of producing engineered binding proteins
WO1994000469A1 (en) * 1992-06-26 1994-01-06 Immunex Corporation Novel tyrosine kinase
US5405941A (en) * 1993-04-15 1995-04-11 National Jewish Center For Immunology And Respiratory Medicine MEKK protein, capable of phosphorylating MEK

Also Published As

Publication number Publication date
WO1998018914A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
AU4851097A (en) Multiple-size cervical collar
HUP9700636A3 (en) Novel estrogen receptor
AU5154098A (en) Soluble tie2 receptor
AU3577197A (en) Voice-pager system
AU4400597A (en) Indole derivatives
AU3427697A (en) Securing-piece attaching apparatus
AU4005597A (en) Steel-wood system
AU5506896A (en) Human p2x4 receptor splice-variants
AU7132898A (en) Edg-1-like receptor
AU5143398A (en) Connecting device
AU6450196A (en) Hr-1 receptor
GB9617923D0 (en) Novel receptor
AU4058697A (en) Line array
AU4646097A (en) Improved multiple-burst-correction system
AU6175696A (en) Hr-1 receptor
AUPO169496A0 (en) Termite-proofing system
GB9609443D0 (en) Transfers
AU3061497A (en) Icebreaker attachment
AU2181197A (en) Connecting part
AUPO938697A0 (en) Novel receptor
AU4753496A (en) Human g-protein coupled receptor
AU4643397A (en) Linkage support system
AU1671597A (en) Indole derivatives
AUPO039696A0 (en) Improved anchoring system
AU5255498A (en) Human kdel receptor